Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis

Correction: Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis

Bibliographic Details
Main Authors: Gerd R. Burmester, Laura C. Coates, Stanley B. Cohen, Yoshiya Tanaka, Ivana Vranic, Edward Nagy, Irina Lazariciu, All-shine Chen, Kenneth Kwok, Lara Fallon, Cassandra Kinch
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-12-01
Series:Rheumatology and Therapy
Online Access:https://doi.org/10.1007/s40744-023-00615-4
Description
ISSN:2198-6576
2198-6584

Similar Items